Selecting anti-infective agents for the treatment of bone infections

Orthopedics

Volumn 30, Issue 9, 2007, Pages 713-717

  Venugopalan, Veena ^a   Smith, Kelly M ^b   Young, Michael H ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM; CEFAMANDOLE; CEFOXITIN; CEFTRIAXONE; CLINDAMYCIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; NAFCILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; RIFAMPICIN; TIMENTIN;

BONE INFECTION; CLINICAL FEATURE; CLINICAL PRACTICE; DRUG PENETRATION; ENTEROBACTERIACEAE; ENTEROCOCCUS; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; PSEUDOMONAS; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 35948956352     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20070901-26     Document Type: Review

References (36)

1. Berbari EF, Steckelberg JM, Osmon DR. Osteomyelitis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. New York, NY: Churchill Livingstone; 2005:1322-1330.
2. Hughes SP, Anderson FM. Penetration of antibiotics into bone. J Antimicrob Chemother. 1985; 15:517-519.
3. Thomas Rde W, Batten JJ, Want S, McCarthy ID, Brown M, Hughes SP. A new in-vitro model to investigate antibiotic penetration of the intervertebral disc. J Bone Joint Surg Br. 1995; 77:967-970.
4. Malincarne L, Ghebregzabher M, Moretti MV, et al. Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty. J Antimicrob Chemother. 2006; 57:950-954.
5. Walters R, Moore R, Fraser R. Penetration of cephazolin in human lumbar intervertebral disc. Spine. 2006; 31:567-570.
6. Rimmele T, Boselli E, Breilh D, et al. Diffusion of levofloxacin into bone and synovial tissues. J Antimicrob Chemother. 2004; 53:533-535.
7. Breilh D, Boselli E, Bel JC, Chassard D, Saux MC, Allaouchiche B. Diffusion of cefepime into cancellous and cortical bone tissue. J Chemother. 2003; 15:134-138.
8. Lovering AM, Zhang J, Bannister GC, et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother. 2002; 50:73-77.
9. Boselli E, Breilh D, Debon R, et al. Penetration of piperacillin/ tazobactam (4 g/500 mg) into synovial tissue. J Chemother. 2002; 14:54-58.
10. Lovering AM, Walsh TR, Bannister GC, MacGowan AP. The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone. J Antimicrob Chemother. 2001; 47:483-486.
11. Lovering AM, Perez J, Bowker KE, Reeves DS, MacGowan AP, Bannister G. A comparison of the penetration of cefuroxime and cephamandole into bone, fat and haematoma fluid in patients undergoing total hip replacement. J Antimicrob Chemother. 1997; 40:99-104.
12. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004; 364:369-379.
13. Fitzgerald RH Jr. Antibiotic distribution in normal and osteomyelitic bone. Orthop Clin North Am. 1984; 15:537-546.
14. Fitzgerald RH Jr. Moxalactam penetration of normal and osteomyelitic bone. Arch Orthop Trauma Surg. 1983;101:273-281.
15. Daly RC, Fitzgerald RH Jr, Washington JA II. Penetration of cefazolin into normal and osteomyelitic canine cortical bone. Antimicrob Agents Chemother. 1982; 22:461-469.
16. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997; 336:999-1007.
17. Cars O. Pharmacokinetics of antibiotics in tissues and tissue fluids: a review. Scand J Infect Dis Suppl. 1990; 74:23-33.
18. Incavo SJ, Ronchetti PJ, Choi JH, Wu H, Kinzig M, Sörgel F. Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues. Antimicrob Agents Chemother. 1994; 38:905-907.
19. Cunha BA. The use of penicillins in orthopaedic surgery. Clin Orthop Relat Res. 1984; 190:36-49.
20. Smilack JD, Flittie WH, Williams TW Jr. Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob Agents Chemother. 1976; 9:169-171.
21. Parsons RL, Beavis JP, Laurence M, David JA, Paddock GM, Trounce JR. Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapen. Br J Clin Pharmacol. 1978; 6:135-143.
22. Fitzgerald RH, Kelly PJ, Snyder RJ, Washington JA. Penetration of methicillin, oxacillin, and cephalothin into bone and synovial tissues. Antimicrob Agents Chemother. 1978; 14:723-726.
23. Mader JT, Morrison LT, Adams KR. Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis. Antimicrob Agents Chemother. 1987; 31:259-263.
24. Mader JT, Adams K, Morrison L. Comparative evaluation of cefazolin and clindamycin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother. 1989; 33:1760-1764.
25. Schurman DJ, Burton DS, Kajiyama G. Cefoxitin antibiotic concentration in bone and synovial fluid. Clin Orthop Relat Res. 1982; 168:64-68.
26. Fass RJ. Treatment of osteomyelitis and septic arthritis with cefazolin. Antimicrob Agents Chemother. 1978; 13:405-411.
27. MacGregor RR, Gibson GA, Bland JA. Imipenem pharmacokinetics and body fluid concentrations in patients receiving high-dose treatment for serious infections. Antimicrob Agents Chemother. 1986; 29:188-192.
28. Sano T, Sakurai M, Dohi S, et al. [Investigation of meropenem levels in the human bone marrow blood, bone, joint fluid and joint tissues]. Jpn J Antibiot. 1993; 46:159-163.
29. O'Reilly T, Kunz S, Sande E, Zak O, Sande MA, Täuber MG. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. Antimicrob Agents Chemother. 1992; 36:2693-2697.
30. Cluzel RA, Lopitaux R, Sirot J, Rampon S. Rifampicin in the treatment of osteoarticular infections due to staphylococci. J Antimicrob Chemother. 1984; 13(suppl c):23-29.
31. Fong IW, Ledbetter WH, Vandenbroucke AC, Simbul M, Rahm V. Ciprofloxacin concentrations in bone and muscle after oral dosing. Antimicrob Agents Chemother. 1986; 29:405-408.
32. Spizek J, Rezanka T. Lincomycin, clindamycin and their applications. Appl Microbiol Biotechnol. 2004; 64:455-464.
33. Nicholas P, Meyers BR, Levy RN, Hirschman SZ. Concentration of clindamycin in human bone. Antimicrob Agents Chemother. 1975; 8:220-221.
34. Kasten MJ. Clindamycin, metronidazole, and chloramphenicol. Mayo Clin Proc. 1999; 74:825-833.
35. Summersgill JT, Schupp LG, Raff MJ. Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone. Antimicrob Agents Chemother. 1982; 21:601-603.
36. MacLeod CM, Bartley EA, Galante JO, Friedhoff LT, Dhruv R. Aztreonam penetration into synovial fluid and bone. Antimicrob Agents Chemother. 1986; 29:710-712.